Skip to main content
. 2020 Dec 28;16(1):59–68. doi: 10.1007/s11523-020-00780-4

Fig. 1.

Fig. 1

Concentration–time profiles of patients treated with rucaparib (a) 400 mg, (b) 500 mg, and (c) 600 mg twice daily. Colored dots represent the rucaparib concentration measured for each individual; the data in black represent the mean rucaparib concentration. Pt patient